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Recently, extracted teeth have been identified as a viable source of stem cells for tissue regenerative approaches. Current expansion of
these cells requires incorporation of animal sera; yet, a fundamental issue underlying cell cultivation methods for cell therapy regards
concerns in using animal sera. In this study, we investigated the development of a chemically defined, serum-free media (K-M) for
the expansion of human periodontal ligament stem cells (PDLSCs) and human stem cells from exfoliated deciduous teeth (SHEDs).
Proliferation assays were performed comparing cells in serum-containing media (FBS-M) with cells cultured in four different serum-free
medium and these demonstrated that in these medium, the cell proliferation of both cell types was significantly less than the proliferation
of cells in FBS-M. Additional proliferation assays were performed using pre-coated fibronectin (FN) tissue culture plates and of the four
serum-free medium, only K-M enabled PDLSCs and SHEDs to proliferate at higher rates than cells cultured in FBS-M. Next, alkaline
phosphatase activity showed that PDLSCs and SHEDs exhibited similar osteogenic potential whether cultured in K-M or FBS-M, and,
additionally, cells retained their multipotency in K-M as seen by expression of chondrogenic and adipogenic genes, and positive Von Kossa,
Alcian blue, and Oil Red O staining. Finally, differential expression of 84 stem cell associated genes revealed that for most genes, PDLSCs
and SHEDs did not differ in their expression regardless of whether cultured in K-M or FBS-M. Taken together, the data suggest that K-M
can support the expansion of PDLSCs and SHEDs and maintenance of their multipotency.
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DOI: 10.1002/jcp.22304Cell therapy has tremendous potential in regenerative
medicine, yet, there are concerns in the utility of cell therapy
due to questions regarding different cell harvest and cultivation
methods (Mannello and Tonti, 2007; Haack-Sorensen et al.,
2008). Bone marrow derived stem cells have been identified for
a number of years, and there are several of ongoing clinical trials
exploring the safety and efficacy of their use for different of
clinical applications (Battiwalla and Hematti, 2009; Sadan et al.,
2009; Satija et al., 2009). There has been an increased interest in
recent years in the potential of oral-derived stem cells for cell
therapy, primarily because they can be derived from a readily
available source, extracted teeth (Gronthos et al., 2000; Miura
et al., 2003; Seo et al., 2004). These cells exhibit multipotency
and regenerative capacities characteristic of mesenchymal stem
cells (Batouli et al., 2003; Shi et al., 2005) and have the capacity
to repair and regenerate tooth structures in vivo (Krebsbach
and Robey, 2002; Mao et al., 2006). Because oral-derived stem
cells have been more recently identified, clinical protocols are
still being developed for their use. Regardless of the specific
protocol used, most current cell therapy approaches rely upon
ex vivo cell expansion in order to produce sufficient cell
numbers for transplantation. Though a wide variety of
protocols and culturing methods exist, one common aspect to
most of them is the inclusion of animal sera for cell expansion, in
that it contains a rich source of nutrients and growth factors
(Mannello and Tonti, 2007). Despite the widespread standard
use of animal sera for in vitro cell culture (Freshney, 2000),
there are several problems which exist relative to its use for
clinical application.
One of the central issues regarding limitations in using animal
sera for clinical cell therapy protocols is that its components are
highly variable and, in many cases, unknown. Though
components of sera have been identified, it has also been
demonstrated that consistency between different lots cannot
be assured (Price and Gregory, 1982). In the context of 2 0 1 0 W I L E Y - L I S S , I N C .multipotent stem cells, serum components and concentrations
have significant impact on cell survival and proliferative capacity,
phenotype, and multipotent potential (Sotiropoulou et al.,
2006; Agata et al., 2009). Additionally, for clinical use, the
inclusion of xenogeneic serum for cell expansion carries
immunological risks associated with the immunogenicity of
serum proteins and the potential of transmission of prion
diseases and zoonoses (Shahdadfar et al., 2005). These
concerns have led to efforts aimed at incorporating FBS
alternatives in cell expansion protocols, including the use of
autologous and allogeneic sera, and the proprietary
manufacturing of serum-free media formulations by different
companies (Nakamura et al., 2008). Even with these
approaches, there are limitations in the availability of both
autologous and allogeneic sera and companies do not freely
disclose their proprietary ‘‘serum-free’’ media components.
These factors not only prohibit clinical translation, but also limit
widespread use and study of more basic fundamental questions
regarding specific mechanisms involved in the modulation of
these media on cell function. As such, there exists a need for the
development of chemically defined media which can propagate
the cultivation of stem cells without adversely affecting cell
function and phenotype (Mannello and Tonti, 2007).
D E V E L O P M E N T O F A S E R U M - F R E E S Y S T E M 67In this study, we aimed to develop a serum-free media (K-M)
for the expansion of dental-derived stem cells, including stem
cells-derived from exfoliated deciduous (baby) teeth (SHEDs)
and periodontal ligament stems cells (PDLSCs). Cell expansion
in this media was compared to standard FBS containing media
used to culture these cells, as well as three other serum-free
media formulations (two of which are commercially available)
used for culture of mesenchymal stem cells. Additionally,
through differentiation assays and microarray analyses,
multipotency and differential gene expression of 84 stem cell
associated genes was examined between cells cultured in K-M
versus those cultured in FBS-containing media.Materials and Methods
Isolation of dental-derived stem cells (PDLSCs, SHEDs)
PDLSCs and SHEDs were harvested as previously described (Miura
et al., 2003; Seo et al., 2004). Briefly, PDLSCs were scraped from
the root surface of a tooth into a p60 dish containing minimum
essential alpha medium (aMEM, Gibco, Carlsbad, CA) and SHEDs
were harvested by scraping out the dental pulp tissue from a
deciduous tooth into a p60 dish containingaMEM. After collection,
the cells were centrifuged at 1,600 rpm for 5 min at room
temperature. The supernatant was aspirated and the cells were
resuspended in a phosphate buffered saline (PBS; Gibco #14190)
solution with 4 mg/ml Dispase II (Roche #04 942 078 001) and
2 mg/ml Collagenase Type II (Worthington #LS004196) and
incubated at 378C for 60 min. The enzyme solution was inactivated
with 5 ml of aMEM-15% FBS-100mM ascorbic acid 2 phosphate
(ASAP, Sigma A-8960, St. Louis, MO) and centrifuged at 1,600 rpm
for 5 min at room temperature. Cells were resuspeneded in 5 ml
aMEM-15% FBS-0.1 mM ASAP and transferred to T-25 flasks.
Media was changed the next day and then every 2–3 days.
Cell culture
Cells were expanded in culture in aMEM, Iscove’s modified
Dulbecco’s media (IMDM, Gibco–Invitrogen #12571), Gibco Stem
Pro Mesenchymal Stem Cell Serum-Free Media (MSCSFM;
Invitrogen #A1033401, Carlsbad, CA) or Lonza Therapeak
Mesenchymal Stem Cell Growth, Media-Chemically Defined
(Walkersville, MD) (MSCGM-CD; Lonza #00190632) and grown in
a 378C humidified tissue culture incubator at 5% CO2. Media
formulations are as follows: aMem (Gibco–Invitrogen #12571)
with 15% FBS (Gibco–Invitrogen-16000), 100mM ASAP and 5mg/
ml Gentamicin (Invitrogen # 15750060) (FBS-M); aMem with 2%
bovine serum albumin (BSA; Sigma A7888), 10mg/ml human insulin
(Sigma), 4mg/ml low density lipoprotein, 200mg/ml transferrin,
10 nM dexamethasone, 100mM ASAP, 50mM b-mercaptoethanol,
5mg/ml gentamicin, 10 ng/ml platelet-derived growth factor
(PDGF; Sigma), 10 ng/ml epidermal growth factor (EGF; R&D
Systems), 10 ng/ml basic fibroblast growth factor (b-FGF, Sigma)
(SDM); IMDM with 0.2% BSA, SITE 3 (Sigma #S5295), 384mM
ASAP, 10 ng/ml PDGF, 10 ng/ml hydrocortisone 5 ng/ml b-FGF,
1 ng/ml EGF, 107 mg/ml parathyroid hormone (PTH) and 5mg/ml
gentamicin (K-M). Media on the cells were changed every 2 or
3 days. Cells were grown in T-150 flasks to about 80% confluency
then media was aspirated from the flasks, cells were washed with
PBS and trypsinized with TrypLE Express (Gibco #12605) before
being split into 12 well plates for the assays.
Fibronectin coating of tissue culture plates
Fibronectin (FN) was coated on the plates and flasks to provide
growth and attachment support for cells grown in the serum-free,
IMDM media. For the 12 well plates, 0.1% FN solution (Sigma
F-1141) was diluted in PBS so that each well received 3.8mg per
well (1mg FN/cm2). The T-150 flasks were coated so that each
received 150mg of FN (1mg FN/cm2). The plates and flasks wereJOURNAL OF CELLULAR PHYSIOLOGYtilted back and forth to ensure complete coverage of the FN
solution. The FN coating was allowed to stand at room
temperature for 90 min. The FN solution was then aspirated before
the resuspended cells were transferred to the flasks and plates.
Proliferation assays
After trypsinization cells were resuspended in an equal amount of
the appropriate media before an aliquot was removed for counting
on a hemocytometer to determine the concentration. The cells
were then centrifuged at 1,600 rpm for 5 min at room
temperature. Cells were resuspended in the appropriate media
at a concentration of 3,800 cells/ml. One milliliter of cells was
dispensed into each well of a 12 well plate. K-M plates were
precoated with FN solution (as outlined above). Four plates for
each cell type and media condition were plated and counted on
a hemocytometer at Days 1, 3, 5, and 7 to determine the cell
numbers within each well. All experiments were performed in
triplicate.
RNA isolation and purification for microarray
PDLSCs and SHEDs were grown in T-75 flasks to 80% confluency
before the cells were harvested for RNA. The Trizol method
(Invitrogen) was used for RNA isolation. This involved adding
Trizol directly to the cells and transferring this cell suspension
to polypropylene tubes. RNA was isolated from the cells by a
Trizol-choloroform extraction, isopropanol precipitation, an
ethanol rinse and resuspension of the RNA pellet in
Diethylpyrocarbonate (DEPC) water. The RNA was further
purified by column chromatography, following manufacturer’s
instructions (Qiagen RNeasy Kit #74104), and resuspended in
DEPC water. RNA concentration was determined by the 260/280
absorbance measurement using a Beckman DU540
spectrophotometer.
In vitro multilineage differentiation
Multipotency of PDLSCs and SHEDs was determined through
lineage specific osteogenic, chondrogenic, and adipogenic
induction, according to previously described methods (Pittenger et
al., 1999). Briefly, cells were plated at a density of 30,000 cells/well
in 12 well plates. At 80% confluency cells were induced with
osteogenic [growth media plus 5 mM b-glycerophosphate, 100 nM
dexamethasone, 50mM ascorbic acid 2-phosphate] or
chondrogenic [growth media plus 50mM ascorbic acid
2-phosphate, 100 nM dexamethasone, 5mg/ml human insulin
(Sigma I-9278), 1 ng/ml TGFb, 400mM proline, 1 non-essential
amino acids] or adipogenic [growth media plus 0.5 mM IBMX, 1mM
dexamethasone, 10mg/ml human insulin, 200mM indomethacin]
induction media. Cells were grown at 378C in a humidified 5% CO2
incubator. The media was changed every 2–3 days. At 3 weeks the
cells were fixed and stained as outlined below.
Multipotent staining of PDLSCs and SHEDs
To identify the mineralized nodules, induced PDLSCs and SHEDs
were fixed in 4% paraformaldehyde for 30 min, immersed in fresh
5% silver nitrate and incubated in the dark for 30 min. After washing
in water the PDLSCs and SHEDs were exposed to ultraviolet light
for 30 min followed by a 4 min incubation in 1% sodium thiosulfate
to neutralize the silver nitrate. Cells were washed twice with water
before 1 ml of PBS was added to each well and viewed. Plates were
stored at 48C.
To detect chondrogenic differentiation induced PDLSCs and
SHEDs were fixed in cold 100% methanol for 30 min and then
exposed to 1% alcian blue in 0.1 N HCl for 30 min. Cells were
washed twice with 0.1 N HCl before 1 ml of PBS was added to each
well and viewed. Plates were stored at 48C.
To detect adipogenic differentiation by identifying lipid vesicles,
induced PDLSCs and SHEDs were fixed in 4% paraformaldehyde
68 T A R L E E T A L .for 30 min, and then immersed in 0.3% oil red O solution for 30 min.
Cells were washed twice with water before 1 ml of PBS was added
to each well and viewed. Plates were stored at 48C.
Alkaline phosphatase activity and detection
Early osteogenic differentiation was detected and quantified by the
alkaline phosphatase (ALP) enzyme assay. Cells were plated at a
density of 30,000 cells/well in 12 well plates. At 80% confluence,
cells were induced with osteogenic media as described above. The
media was changed every 2–3 days and after 1 week, ALP activity
was measured.
To detect phosphatase activity, PDLSCs and SHEDs were fixed
in 70% ethanol for 30 min. They were then incubated with freshly
made substrate containing naphthol AS-TR phosphate (Sigma) and
Fast blue (Sigma) for 30 min. Cells were washed twice with PBS
then viewed or stored at 48C.
To quantify the ALP activity and normalize the results, cells were
lysed in Passive Lysis Buffer (Promega, Madison, WI) according to
manufacturer’s instructions. Cell lysates were then sonicated, and
centrifuged (10,000 rpm for 10 min at 48C). The supernatant was
recovered for the quantitative colormetric ALP assay (Manolagas
et al., 1981) and the cell pellet was used for DNA isolation and the
determination of the DNA concentration using the Quant-iTTM
dsDNA BR Assay (Invitrogen) per the manufacturer’s instructions.
Reverse transcriptase polymerase chain reaction (RT-PCR)
To confirm chondrogenic and adipogenic differentiation, total
PDLSC and SHED cellular RNA was extracted, reverse
transcribed, and amplified using osteoblast specific gene primers.
Media from the wells of induced and uninduced PDLSCs and SHEDs
were aspirated. Cells were immediately resuspended in 1 ml of
Trizol (Invitrogen) and RNA was isolated according to the
manufacturer’s instructions. Synthesis of cDNA was performed
using Invitrogen’s SuperScriptII kit and oligo dT. PCR reaction
components and concentrations were as described in the
Invitrogen Platinum Taq polymerase instructions using the primer
sets below. An MJ themorcycler was used for the following two
PCR reaction conditions:
94C 2 minutes ! ½94C 4500 ! 56C 4500 ! 72C 10	
X 35 cycles ! 72C 150or
94C 2 minutes ! ½94C 4500 ! 67C 4500 ! 72C 10	








GAPDH FWD AGCCGCATCTTCTTTTGCGTC 815 NM_002046
GAPDH REV TCATATTTGGCAGGTTTTTCT








Sox 9 FWD TTGAGCCTTAAAACGGTGCT 224 NM000346







JOURNAL OF CELLULAR PHYSIOLOGYStatistical analysis
Statistical analysis was performed with the use of Instat software
(GraphPad Software, San Diego, CA). All data were plotted as
mean
 standard error of the mean (SEM), unless otherwise noted.
Statistically significant differences were determined by two-tailed
Student t tests, and statistical significance was defined as P< 0.05.
Results
Cell growth and proliferation
PDLSCs and SHEDs were cultured for 7 days in four different
media formulations and their proliferative potential was
compared to cells grown in FBS-M. In all serum-free conditions,
after 3 days, the cell proliferation of both cell types was<70% of
the proliferation rate of cells grown in FBS-M and by day 5, this
decreased to<50%. Neither of the cell types proliferated to the
same degree as cells grown in FBS-M, though cells seemed to
grow best in the Lonza media and K-M, particularly the SHEDs
(Fig. 1a,b). Additionally, relative to cell cultures in the FBS-M, in
all cultures grown in serum-free media there were larger
numbers of floating and non-adhering cells at Day 1 and
throughout the timecourse of the study. This suggested that the
cells did not have sufficient initial adherence, limiting their
capacity to sustain cell growth over time.
The next set of studies followed from the first set and aimed
to evaluate the cell adhesive and proliferative effect of providing
an extracellular matrix (ECM) coating on the cell culture
growth surface. PDLSCs and SHEDs were expanded in K-M and
Lonza medium and FN was coated on these tissue culture plates
prior to plating of cells. Over time, PDLSCs and SHEDs cultured
in K-M exhibited morphology no different than those seen inFig. 1. Proliferation of dental-derived stem cells in serum-free
media. a: PDLSCs and (b) SHEDs were cultured for 7 days in four
different media formulations and their proliferative potential was
compared to cells grown in FBS-M. Cell numbers are plotted relative
to the same cells grown in FBS during this same time period. [Color
figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
Fig. 2. Proliferation of dental-derived stem cells in serum-free
media with fibronectin (FN). Photomicrographs of PDLSCs in (a) K-M
and (b) FBS-M; SHEDs in (c) K-M and (d) FBS-M. Proliferation plots of
(e) PDLSCs and (f) SHEDs in serum-free media on plates pre-treated
with FN. These data are plotted directly against cells grown in serum
containing media (FBS-M). MDenotes P < 0.05 relative to FBS
condition. [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
TABLE 1. Upregulated expression of PDLSC genes in K-M versus
FBS-M
Functional gene grouping Fold increase
Stem cell associated genes
Markers of ‘‘stemness’’
Leukemia inhibitory factor (LIF) 8.0
Insulin 5.7
Telomerase reverse transcriptase (TERT) 5.1
Wnt3A 4.0




Nerve growth factor receptor 10.2
Prominin1 (CD133) 8.7
Frizzled homolog 9 (FZD9) 5.6
Fucosyltransferase 4 (FUT4) 3.8
Vascular cell adhesion molecule-1 (CD106) 3.4
NT5E (CD73) 2.8
Encodes epidermal GF receptor-2 (ERBB2) 2.6
Other MSC associated genes
Hepatocyte growth factor 128.5
Vascular endothelial growth factor-A (VEGF-A) 13.2
Colony stimulating factor 3 (G-CSF-3) 12.0
Von Willebrand factor 10.2
Interferon gamma 6.4
Epidermal growth factor 5.2
Interleukin-1b (IL-1b) 4.3
Solute carrier family 17 (SLC17A5) 4.2
Insulin-like growth factor 1 3.3
Fucosyltransferase 1 3.3
Matrix metallopeptidase-2 (MMP-2) 2.6




Bone morphogenetic protein-2 (BMP-2) 17.0
Bone morphogenetic protein-6 (BMP-6) 8.1
HNF1 homeobox A 8.0
Runt-related transcription factor 2 2.6
PTK2 protein tyrosine kinase 2 2.3
‘‘Adipogenic’’ genes
Peroxisome proliferator-activated receptor (PPARG) 13.7
‘‘Chondrogenic’’ genes
Sex determining region Y (SRY)-box (SOX9) 28.8
Growth differentiation-7 (GDF-7) 6.4
Integrin, alpha X (CD11c) 4.1
D E V E L O P M E N T O F A S E R U M - F R E E S Y S T E M 69cells cultured in FBS-M (Fig. 2a–d). The proliferation assays
revealed that when grown in K-M, PDLSCs in K-M exhibited
significantly higher proliferation rates by day 7 (Fig. 2e) when
compared to PDLSCs cultured in FBS-M. On the other hand,
by day 5 of the 7-day timecourse, SHEDs proliferated at
significantly (P< 0.05) higher rates than cells in FBS-M (Fig. 2f).JOURNAL OF CELLULAR PHYSIOLOGYThough the Lonza media supported the proliferation of SHEDs
equivalent to that seen in K-M, PDLSCs in this media did not
proliferate to the same degree as in the control FBS-M or K-M.
Similar proliferation assays were conducted with dental pulp
stem cells (DPSCs) and bone marrow derived stem cells
(MSCs) and the K-M did not support proliferation of either cell
type to the same degree as the FBS-M (data not shown).
Differential gene expression of PDLSCs and SHEDs
in K-M versus FBS-M
Both PDLSCs and SHEDs cultured in K-M exhibited a greater
proliferative capacity than when cultured in FBS-M, and thus, we
next wanted to determine if K-M had effects on gene expression
of these two cell types. Eighty-four stem cell associated genes
were analyzed for differential expression when cells were
cultured in K-M relative to when cultured in FBS-M. Following
1 week of culture in the respective media, genes associated
with ‘‘stemness’’ and lineage specific genes were analyzed with
RT-PCR microarray and genes exhibiting a greater than twofold
difference in expression between the conditions were
reported. Table 1 shows upregulated ‘‘stemness’’ associated
genes when PDLSCs were cultured in K-M, relative to FBS-M.
Overall, the K-M media appeared to support a significant
(>2-fold) upregulation in expression of genes associated with
mesenchymal stem cells and ‘‘stemness,’’ particularly when
compared to downregulated gene expression of ‘‘stemness’’
TABLE 2. Downregulated expression of PDLSC genes in K-M versus
FBS-M
Functional gene grouping Fold decrease
Stem cell associated genes
Markers of ‘‘stemness’’
Fibroblast growth factor 2 (FGF-2) 2.6
MSC specific markers
Integrin, alpha 6 2.2
Other MSC associated genes




Bone morphogenetic protein-4 (BMP-4) 13.5
‘‘Myogenic’’ genes
Jagged 1 (Jag1) 4.2
TABLE 4. Downregulated expression of SHED genes in K-M versus FBS-M
Functional gene grouping Fold decrease
Stem cell associated genes
Markers of ‘‘stemness’’
Fibroblast growth factor 2 (FGF-2) 4.9
POU class 5 homeobox 1 (Oct-4) 3.9
MSC specific markers
Vascular cell adhesion molecule-1 (CD106) 44.8
Activated leukocyte cell adhesion molecule 3.7
Other MSC associated genes
Interleukin-6 67.8
Brain-derived neurotrophic factor (BDNF) 7.7
Insulin-like growth factor 1 7.3
Collagen, type I, alpha 1 5.3
Protein tyrosine phosphatase, receptor 4.1
Nudix 3.2
Intercellular adhesion molecule 1 2.8





SMAD specific E3 ubiquitin protein 3.3
Fibroblast growth factor-10 2.4
‘‘Adipogenic’’ genes
Ras homologue gene family member (RHOA) 2.1
‘‘Chondrogenic’’ genes
Growth differentiation-5 (GDF-5) 5.3
Bone morphogenetic protein-4 (BMP-4) 2.2
Growth differentiation-6 (GDF-6) 2.1
70 T A R L E E T A L .and mesenchymal stem cell associated genes (Table 2).
Differential expression (up- and down-regulation) of lineage
specific genes is also seen between the two culture conditions,
but only for a few lineage specific genes (Tables 1 and 2).
In analysis of differential gene expression of SHEDS grown in
the two different media, there appeared to be the same degree
of up- and down-regulation of different ‘‘stemness’’ associated
genes and lineage specific genes (Tables 3 and 4). Taken
together, these data suggest that while expansion of SHEDs
in K-M resulted in differential expression of different genes
associated with ‘‘stemness’’ and lineage specific differentiation,
there appeared to be no net difference in the number of up- and
down-regulated genes. Yet, for PDLSCs cultured between the
two conditions, the K-M appeared to ‘‘hold’’ cells in a greater
state of ‘‘stemness,’’ as evidenced by the upregulation of
‘‘stemness’’ associated genes when cultured in this media.
Osteogenic potential of PDLSCs and SHEDs in K-M
Because PDLSCs and SHEDs have demonstrated the capacity
for osteogenic differentiation when cultured in the presence of
osteogenic inductive factors, we examined the ability of K-M to
support the growth of PDLSCs and SHEDS while maintaining
their capacity for osteogenic differentiation. To evaluate this,
cells were expanded for 7 days in either K-M or FBS-M and thenTABLE 3. Upregulated expression of SHED genes in K-M versus FBS-M
Functional gene grouping Fold increase








Other MSC associated genes
Colony stimulating factor 3 (G-CSF-3) 5.0
Hepatocyte growth factor 4.9
Nestin 3.5
Solute carrier family 17 (SLC17A5) 2.6
Von Willebrand factor 2.5
Colony stimulating factor 2 (G-CSF-2) 2.4




Bone morphogenetic protein-2 (BMP-2) 2.4
PTK2 protein tyrosine kinase 2 2.3
‘‘Adipogenic’’ genes
Peroxisome proliferator-activated receptor (PPARG) 10.8
‘‘Chondrogenic’’ genes
Sex determining region Y (SRY)-box (SOX9) 4.5
JOURNAL OF CELLULAR PHYSIOLOGYcultured in osteoinductive media (containing FBS) for 7 days.
Alkaline phophatase activity was analyzed quantitatively
following 1 week of culture in osteoinductive media and in both
SHEDs and PDLSCs, there were no differences in Alk-P activity
between cells expanded in K-M versus those expanded in
FBS-M (Fig. 3a,b). This demonstrated that both cell types
maintained their capacity for osteogenic differentiation
following cell expansion in K-M.
Maintenance of PDLSC and SHED multilineage
potential in K-M
PDLSCs and SHEDS were assessed for their capacity to
differentiate towards different cellular lineages following
cell expansion in K-M and FBS-M. Lineage specific induction
under traditional adipogenic, chondrogenic, and osteogenic
conditions was performed and these conditions incorporated
serum in the induction media. Following 1 week of induction,
RT-PCR was performed to examine gene expression of
adipogenic (PPARg2, LPL) (Fig. 4a) and chondrogenic (SOX9,
coll. II) (Fig. 4b) markers in their respective conditions.
Additionally, PDLSCs and SHEDs were stained with Von Kossa,
Alcian blue, and Oil Red O. In control culture conditions, Von
Kossa, Alcian blue, and Oil Red O staining were all negative.
Under osteogenic culture conditions, PDLSCs expanded in
either FBS-M or K-M exhibited a similar pattern of Von Kossa
staining, which indicated deposition of mineralized matrix
indicative of osteoblasts (Fig. 5a). Similarly, in cells grown under
chondrogenic conditions following culture expansion in either
FBS-M or K-M, the presence of chondrogenic proteoglycans
was indicated by positive Alcian blue staining (Fig. 5a),
confirming chondrogenic differentiation. In adipogenic
conditions, Oil Red O staining was used to detect intracellular
lipid-rich vacuoles and morphological changes in cell shape.
The results confirmed that under these conditions, PDLSCs
expanded in either FBS-M or K-M exhibited no difference in
their capacity to differentiate toward an adipogenic lineage
(Fig. 5a). As was the case with the PDLSCs, SHEDs expanded
in FBS-M or K-M exhibited comparable levels of differentiation
towards osteogenic, chondrogenic, and adipogenic lineages as
Fig. 3. Osteogenic potential of PDLSCs and SHEDs following
expansion in K-M R FN. Alkaline phosphatase activity representing
the osteogenic induction potential of (a) PDLSCs and (b) SHEDs
following culture expansion in either FBS-M or K-M and 1 week
induction in conventional osteogenic induction media (containing
FBS). [Color figure can be viewed in the online issue, which is available
at wileyonlinelibrary.com.]
Fig. 4. K-M expanded PDLSC and SHED expression of lineage
specific genes following adipogenic and chondrogenic induction.
Following 1 week of induction, RT-PCR was performed to examine
gene expression of (a) adipogenic (PPARg2, LPL) and (b)
chondrogenic (SOX9, coll. II) markers in their respective conditions.
D E V E L O P M E N T O F A S E R U M - F R E E S Y S T E M 71evidenced through similar patterns of Von Kossa, Alcian Blue,
and Oil Red O staining (Fig. 5b).
Discussion
Oral-derived stem cells have clinical potential for cell therapy
applications in craniofacial regeneration; yet, one of the possible
limitations with the clinical utility of these cells is that all current
cell culture protocols for their expansion incorporate
animal sera. In this report, we describe the development
of a chemically defined, serum-free media (K-M) for the cell
expansion of dental-derived stem cells. PDLSCs and SHEDs
cultured in K-M proliferated at rates faster than when these
cells were cultured in media containing serum (FBS-M).
Microarray analyses showed that overall, PDLSCs and SHEDs
in K-M expressed more ‘‘stemness’’ markers, when compared
to those cells in FBS-M. Finally, PDLSCs and SHEDs were able
to maintain their capacity for osteogenic differentiation as
well as their multilineage potential following culture in K-M.
It has been well-established that the components of serum
contain rich nutrients and growth factors which support cell
growth in culture (Price and Gregory, 1982; Satija et al., 2007).
Yet, in the context of clinical applications, efforts to develop
chemically defined, serum-free media to support growth ofJOURNAL OF CELLULAR PHYSIOLOGYdifferent mesenchymal cell types are not new (Koller et al.,
1998; Sotiropoulou et al., 2006; Mannello and Tonti, 2007).
From a biology standpoint, the development of serum deprived
growth media enables the study of growth factors, hormones
and other compounds on cell cultures without the confounding
effects of the possible presence of these components in serum
(Lennon et al., 1995). Serum-free media has been examined for
the cell expansion of bone marrow-derived stromal cells, and
more recently, commercially developed serum-free media and
serum substitutes have been developed for these cells. Despite
the variety of different formulations examined, there appear to
be a few common elements of animal sera to which all serum-
free media formulations aim to replace or substitute, including:
vitamins, hormones, transport proteins, essential elements,
lipids, and growth factors. Because marrow derived
mesenchymal stem cells share similar properties with certain
populations of oral-derived stem cells, we took a similar
approach in our efforts to develop a serum-free media for
oral-derived stem cells. Replacement of an often overlooked
component of serum, vitamins, served as the rationale in using
IMDM media as the basal media. It contains high concentrations
of vitamins and glucose, relative to other commonly used basal
media (i.e., DMEM, aMEM) for cell culture. Another important
source of key components was derived from the SITE 3
supplement, which provided transferrin and a source of lipids
and trace elements. Transferrin, due to its iron-binding
properties, is a critical component of chemically defined media
due to its ability to transport iron (an essential trace element)
Fig. 5. Multipotency of PDLSCs and SHEDs following expansion in
K-M R FN. a: Following culture expansion in either FBS-M or K-M,
PDLSCs were induced to differentiate in osteogenic, chondrogenic,
and adipogenic media; photomicrographs show multipotent
mesenchymal differentiation as measured by phenotypic expression
of osteogenic mineralized matrix (Von Kossa), chondrogenic
proteoglycans (Alcian blue), and adipogenic lipid vacuoles (Oil Red O)
(images shown at 200T magnification). b: Von Kossa, Alcian blue, and
Oil Red O staining of induced (osteogenic, chondrogenic, adipogenic)
SHEDs following culture expansion in FBS-M or K-M. [Color figure
can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
72 T A R L E E T A L .across cell membranes (Barnes and Sato, 1980; Lennon et al.,
1995). Selenium, also an essential trace element, is contained
within the SITE 3 supplement as well, and is involved in cell
growth (McKeehan et al., 1976). The other components of SITE
3 are insulin, ethanolamine, linoleic acid, and oleic acid. Insulin is
a hormone that promotes the uptake of glucose and amino acids
and serves as a mitogen for in vitro culture of cells due to its role
in fatty acid and glycogen syntheses. The fatty acids
(ethanolamine, linoleic acid, and oleic acid) are important
nutrients for many cells in that they are involved in cell growth
and also serve as key components of the cell membrane
(Murakami et al., 1982; Kovar, 1987). Finally, serum bovine
albumin (BSA) is contained within SITE 3 and due to the critical
role it plays as a fatty acid carrier (Guilbert and Iscove, 1976;
Nilausen, 1978), additional BSA was directly added to the K-M
culture medium at a concentration of 0.2%.
Other key components of the K-M media were ascorbic acid,
exogenous hormones (PTH and hydrocortisone), and growth
factors (PDGF, EGF, FGF). Though ascorbic acid is often
incorporated into ‘‘osteoinduction media’’ for mesenchymal
cells (Pittenger et al., 1999), historically, it has been implicated in
the biosynthesis of extracellular matrix components such as
collagen and increases the cell proliferation of mesenchymal
cells in culture (Hata and Senoo, 1989; Harada et al., 1991). PTH
has been shown to be required for serum-free growth of cell
cultures (Bottenstein et al., 1979) and in testing of 37 lots of fetalJOURNAL OF CELLULAR PHYSIOLOGYbovine serum, Price and Gregory found that serum lots
contained on average, 1,718 pg/ml, with ranges between 85 and
6,180 pg/ml (Price and Gregory, 1982). Thus, we incorporated
this into the K-M but in comparison to when it was not added to
the media, no effects were observed on proliferation and gene
expression of mesenchymal markers (data not shown). On the
other hand, though we did not perform separate studies with or
without inclusion of growth factors, inclusion of PDGF, EGF,
and b-FGF in serum-free medium for bone marrow derived
mesenchymal stem cells has been shown to be critical for cell
proliferation and in vitro colony-forming potential (Gronthos
and Simmons, 1995; Lennon et al., 1995; Kuznetsov et al., 1997).
Through the utilization of blocking antibodies in serum-free
media containing marrow stromal cell conditioned media,
Kuznetsov et al. determined that the proliferation of marrow
stromal fibroblasts requires participation of at least four growth
factors: PDGF, bFGF, TGF-beta, and EGF. These results are in
accord with findings from Lennon et al., which demonstrated
that addition of PDGF and FGF to serum-free cultures of
mesenchymal stem cells are critical in maintaining proliferation
rates comparable to rates seen when cells are cultured in FBS. In
the context of colony forming potential (CFU-F), through a
series of exhaustive experiments studying the effects of
individual growth factors and growth factor combinations on
colony formation of bone marrow derived stromal cells,
Gronthos et al. determined that exogeneous growth factor
inclusion into serum-free media is necessary for clonal growth
and development (Gronthos and Simmons, 1995). Though we
did not examine CFU-F potential in these studies, we did
examine proliferation rates of SHEDs, PDLSCs, and DPSCs
with the media Gronthos et al. used in their studies and did not
see proliferation of oral-derived stem cells beyond Day 5, with
most of the cells beginning to die off and detach from the culture
plates at this point. Though proliferation was observed in the K-
M, we saw an increase in initial cell non-adherence and cell
detachment over time, relative to cells cultured in FBS-M. This
observation served as the rationale to incorporate the FN
coating step as part of the cell expansion process, attempting to
enhance cell adherence through utilization of an ECM coating
on the tissue culture plates. The role of cell adhesion molecules
contained in serum, namely fibronectin, has long been
established. These molecules play important roles in promotion
of cell attachment, proliferation, and differentiation and as such,
efforts are often made in order to recapitulate the effects of
these factors through the use of fibronectin, laminin, and
collagen (Steele et al., 1993; Mauney et al., 2006). In our system,
we showed that the additional step of providing a FN coating
upon which the cells could attach was pivotal in attaining cell
(SHEDs, PDLSCs) proliferation rates in K-M comparable and
greater than those seen in FBS-M.
Though it was clearly demonstrated that cells could be
expanded in K-M on FN, it was more critical to determine if
these cells could retain their multipotency following culture
in K-M. When the switch was made to conventional
‘‘lineage-specific induction’’ conditions with the incorporation
of FBS (Pittenger et al., 1999), PDLSCs and SHEDs exhibited
the ability to differentiate down osteogenic, adipogenic, and
chondrogenic pathways. Though the PDLSCs and SHEDs
were able to retain their capacity for differentiation following
culture in K-M, the observation of an increase in proliferation
rate suggested that the cells were less differentiated while
growing in K-M, hence, exhibiting higher proliferative capacity.
Further support that K-M appeared to maintain the cells in a
less differentiated state, or greater state of ‘‘stemness,’’ was
provided by the observation of greater expression of stemness
markers during culture in K-M, particularly by the PDLSCs.
Additionally, it should be noted that when attempts were made
to osteogenically induce cells (as described in the Materials and
Methods Section) while leaving in K-M, cells did not show
D E V E L O P M E N T O F A S E R U M - F R E E S Y S T E M 73the capacity for induction (data not shown), further suggesting
that this media may be ‘‘holding’’ them in a greater state of
‘‘stemness.’’ If, in fact, this is the case, it could hold implications
for therapeutic approaches to utilization of these cells.
Of particular interest are the PDLSCs, which demonstrated
significant upregulation (>2-fold) of 36 of the 84 stem cell
associated genes analyzed when culture in K-M relative to FBS-
M, the majority of these being genes associated with ‘‘stemness’’
or ‘‘undifferentiated’’ stem cell phenotypes. Further studies
need to be performed in order to more clearly elucidate this
hypothesis based on these initial observations.
As noted, due to concerns regarding the use of animal sera in
cell therapy applications, there have been efforts to develop
serum-free media formulations for the culture of bone marrow
derived mesenchymal cells for the exploitation of their clinical
utility. Serum-free media also allow more in depth study of
specific growth factors effects on cells without the confounding
factor of the various unknown components and effects of animal
sera. Though oral-derived stem cells have similarities to bone
marrow derived stem cells in their phenotypes and
regenerative applications, a distinct therapeutic advantage of
oral-derived stem cells is their availability, in that they are
derived from non-functional tissues (i.e., extracted teeth).
Though these studies provide early evidence of the
development of a serum-free media capable of supporting the
expansion and multipotency of PDLSCs and SHEDs, the true
test of efficacy will be to determine if these cells cultured in K-M
can retain their regenerative potential in vivo. Another key
point to address will be to determine if these cells can be
harvested, isolated, and expanded without ever being exposed
to animal sera and further, if this impacts immunomodulatory
properties these cells have been shown to possess (Wada et al.,
2009). Studies are currently being planned which aim to address
these points and more rigorously elucidate some of the
mechanistic effects of specific components of the K-M media
on regulation of gene expression and modulation of cell
phenotype.
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